NCT05682716View on ClinicalTrials.gov

Application of Intraoperative Transesophageal Echocardiography Imaging of Vein and CLCVP in Early Prediction and Intervention CSA-AKI

NACompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

November 29, 2022

Study Completion Date

December 27, 2022

Conditions
Acute Kidney Injury
Interventions
COMBINATION_PRODUCT

Controlled low central venous pressure (CLCVP) technology

Controlled low central venous pressure (CLCVP) technology: after cardiopulmonary bypass, pumping nitroglycerin (0.2-1 ug/kg \* min) and other methods until the end of surgery to maintain the central venous pressure below 10 mmHg.

DRUG

Nitroglycerin

nitroglycerin (0.2-1 ug/kg \* min)

Trial Locations (1)

210012

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER